Year |
Citation |
Score |
2018 |
Mason BD, Hartkopf WI, Miles KN, Subasavage JP, Raghavan D, Henry TJ. Speckle Interferometry of Red Dwarf Stars The Astronomical Journal. 155: 215. DOI: 10.3847/1538-3881/Aab9B8 |
0.508 |
|
2016 |
Richardson ND, Moffat AFJ, Maltais-Tariant R, Pablo H, Gies DR, Saio H, St-Louis N, Schaefer G, Miroshnichenko AS, Farrington C, Aldoretta EJ, Artigau É, Boyajian TS, Gordon K, Jones J, ... ... Raghavan D, et al. Spectroscopy, MOST photometry, and interferometry of MWC 314: Is it an LBV or an interacting binary? Monthly Notices of the Royal Astronomical Society. 455: 244-257. DOI: 10.1093/Mnras/Stv2291 |
0.751 |
|
2014 |
Richardson ND, Moffat AFJ, Maltais-Tariant R, Pablo H, Gies DR, St-Louis N, Schaefer G, Miroshnichenko AS, Farrington C, Aldoretta EJ, Artigau É, Boyajian T, Gordon K, Goldfinger PJ, Jones J, ... ... Raghavan D, et al. MWC 314: Binary results from optical interferometry compared with spectroscopy and photometry Proceedings of Spie - the International Society For Optical Engineering. 9146. DOI: 10.1117/12.2055364 |
0.744 |
|
2012 |
Raghavan D, Farrington CD, Ten Brummelaar TA, McAlister HA, Ridgway ST, Sturmann L, Sturmann J, Turner NH. A search for separated fringe packet binaries using the CHARA array Astrophysical Journal. 745. DOI: 10.1088/0004-637X/745/1/24 |
0.733 |
|
2011 |
O'Brien DP, McAlister HA, Raghavan D, Boyajian TS, Ten Brummelaar TA, Sturmann J, Sturmann L, Turner NH, Ridgway S. Inner orbits in hierarchical triple systems from the CHARA Array. I. V819 Her B Astrophysical Journal. 728. DOI: 10.1088/0004-637X/728/2/111 |
0.713 |
|
2011 |
Mason BD, Hartkopf WI, Raghavan D, Subasavage JP, Roberts LC, Turner NH, Ten Brummelaar TA. Know the star, know the planet. II. Speckle interferometry of exoplanet host stars Astronomical Journal. 142. DOI: 10.1088/0004-6256/142/5/176 |
0.495 |
|
2010 |
Raghavan D, McAlister HA, Henry TJ, Latham DW, Marcy GW, Mason BD, Gies DR, White RJ, Ten Brummelaar TA. A survey of stellar families: Multiplicity of solar-type stars Astrophysical Journal, Supplement Series. 190: 1-42. DOI: 10.1088/0067-0049/190/1/1 |
0.704 |
|
2010 |
Farrington CD, Ten Brummelaar TA, Mason BD, Hartkopf WI, McAlister HA, Raghavan D, Turner NH, Sturmann L, Sturmann J, Ridgway ST. Separated fringe packet observations with the CHARA array. I. Methods and new orbits for χ Draconis, HD 184467, and HD 198084 Astronomical Journal. 139: 2308-2318. DOI: 10.1088/0004-6256/139/6/2308 |
0.694 |
|
2009 |
Raghavan D, McAlister HA, Torres G, Latham DW, Mason BD, Boyajian TS, Baines EK, Williams SJ, Brummelaar TAT, Farrington CD, Ridgway ST, Sturmann L, Sturmann J, Turner NH. The visual orbit of the 1.1 day spectroscopic binary σ2 coronae borealis from interferometry at the chara array Astrophysical Journal. 690: 394-406. DOI: 10.1088/0004-637X/690/1/394 |
0.73 |
|
2008 |
Boyajian TS, McAlister HA, Baines EK, Gies DR, Henry T, Jao WC, O'Brien D, Raghavan D, Touhami Y, Ten Brummelaar TA, Farrington C, Goldfinger PJ, Sturmann L, Sturmann J, Turner NH, et al. Angular diameters of the G subdwarf μ Cassiopeiae A and the K dwarfs σ Draconis and HR 511 from interferometric measurements with the Chara array Astrophysical Journal. 683: 424-432. DOI: 10.1086/589554 |
0.707 |
|
2007 |
Grundstrom ED, Blair JL, Gies DR, Huang W, Mcswain MV, Raghavan D, Riddle RL, Subasavage JP, Wingert DW, Levine AM, Remillard RA. Joint Hα and X-ray observations of massive X-ray binaries. I. The B supergiant system LS 1 +65 010 = 2S 0114+650 Astrophysical Journal. 656: 431-436. DOI: 10.1086/510508 |
0.354 |
|
2006 |
Patten BM, Stauffer JR, Burrows A, Marengo M, Hora JL, Luhman KL, Sonnett SM, Henry TJ, Raghavan D, Megeath ST, Liebert J, Fazio GG. Spitzer IRAC photometry of M, L, and T dwarfs Astrophysical Journal. 651: 502-516. DOI: 10.1086/507264 |
0.434 |
|
2006 |
Raghavan D, Henry TJ, Mason BD, Subasavage JP, Jao WC, Beaulieu TD, Hambly NC. Two suns in the sky: Stellar multiplicity in exoplanet systems Astrophysical Journal. 646: 523-542. DOI: 10.1086/504823 |
0.529 |
|
Low-probability matches (unlikely to be authored by this person) |
2014 |
Brendle J, Raghavan D. Bounding, splitting, and almost disjointness Annals of Pure and Applied Logic. 165: 631-651. DOI: 10.1016/j.apal.2013.09.002 |
0.122 |
|
2024 |
Sakthivel DK, Taur P, Paul R, Sundaram PM, Raghavan D. A decade's experience of robotic buccal ureteroplasty for post-ureteroscopic laser lithotripsy-induced strictures-Should this be the new standard? Asian Journal of Urology. 12: 258-261. PMID 40458572 DOI: 10.1016/j.ajur.2024.03.003 |
0.12 |
|
2012 |
Raghavan D, Steinberg M, Sandler H. Neutron radiotherapy in South Africa: Neutron radiotherapy: Abratt supported South African Medical Journal. 102: 271. PMID 22554324 |
0.115 |
|
2015 |
Raghavan D, Sandler HM. Invasive bladder cancer: Combined modality treatment Urological Oncology. 591-608. DOI: 10.1007/978-0-85729-482-1_34 |
0.109 |
|
2023 |
Raghavan D, Kannan D, Sekaran PG, Thangarasu M, J SP, Paul R, Taur P. A Novel Technique of Renorrhaphy in Difficult Partial Nephrectomies by Single-Layered Parenchymal Imbrication. Cureus. 15: e42702. PMID 37654940 DOI: 10.7759/cureus.42702 |
0.106 |
|
2012 |
Raghavan D, Todorcevic S. Cofinal types of ultrafilters Annals of Pure and Applied Logic. 163: 185-199. DOI: 10.1016/J.Apal.2011.08.002 |
0.104 |
|
2007 |
Raghavan D. Proudly presenting COLOURAGE... yet again Colourage. 54: 26+28. |
0.101 |
|
2021 |
Raghavan D, Thangarasu M, J SP, Paul R, Selvaraj N. A Hemostatic Technique in Robot-Assisted Laparoscopic Partial Nephrectomy and Its Impact on Renal Function. Cureus. 13: e15122. PMID 34159024 DOI: 10.7759/cureus.15122 |
0.094 |
|
2003 |
Raghavan D. Progress in the chemotherapy of metastatic cancer of the urinary tract Cancer. 97: 2050-2055. PMID 12673696 |
0.093 |
|
1981 |
Selby P, Raghavan D. Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients Journal of Clinical Pathology. 34: 455-463. PMID 7019254 |
0.09 |
|
1985 |
Pearson BS, Raghavan D. First-line intravenous cisplatin for deeply invasive bladder cancer: Update on 70 cases British Journal of Urology. 57: 690-693. PMID 4084727 |
0.089 |
|
2008 |
Raghavan D. Functionalized clay vinyl ester nanocomposites Materials Research Society Symposium Proceedings. 1137: 197-202. |
0.088 |
|
1990 |
Raghavan D, Rogers J. Update in the management of prostate cancer Medical Journal of Australia. 152: 419-426. PMID 2184331 |
0.086 |
|
2005 |
Balakrishnan S, Raghavan D. Chemically functionalized clay-epoxy nanocomposites: Vernonia oil-based surfactant Journal of Reinforced Plastics and Composites. 24: 785-793. DOI: 10.1177/0731684405047766 |
0.085 |
|
2010 |
Shepard DR, Raghavan D. Innovations in the systemic therapy of prostate cancer Nature Reviews Clinical Oncology. 7: 13-21. PMID 19997075 DOI: 10.1038/nrclinonc.2009.187 |
0.084 |
|
1990 |
Grant AJ, Russell PJ, Raghavan D. Active and pro-plasminogen activator on the surface of human bladder cancer cells derived from a high grade invasive tumour. Biochemical and Biophysical Research Communications. 172: 870-6. PMID 2173583 DOI: 10.1016/0006-291X(90)90756-D |
0.083 |
|
2003 |
Balakrishnan S, Raghavan D. Chemically functionalized clay epoxy nanocomposites for aerospace applications 2003 Nanotechnology Conference and Trade Show - Nanotech 2003. 3: 250-253. |
0.081 |
|
2008 |
Choueiri TK, Raghavan D. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: Persisting uncertainties Nature Clinical Practice Oncology. 5: 444-454. PMID 18577983 DOI: 10.1038/ncponc1159 |
0.081 |
|
2002 |
Emekalam A, Gu X, Raghavan D. Characterization of renewable composites Materials Research Society Symposium - Proceedings. 702: 247-252. DOI: 10.1557/Proc-702-U7.1.1 |
0.08 |
|
2006 |
Raghavan D. Ushering in a new era of consumerism Colourage. 53. |
0.08 |
|
1988 |
Raghavan D. Non-hormone chemotherapy for prostate cancer: Principles of treatment and application to the testing of new drugs Seminars in Oncology. 15: 371-389. PMID 3043671 |
0.08 |
|
1995 |
Raghavan D, Huben R. Management of bladder cancer Current Problems in Cancer. 19: 1-64. PMID 7768113 DOI: 10.1016/S0147-0272(07)80002-X |
0.08 |
|
2004 |
Raghavan D, Skinner E. Genitourinary Cancer in the Elderly Seminars in Oncology. 31: 249-263. PMID 15112154 DOI: 10.1053/j.seminoncol.2003.12.034 |
0.08 |
|
2010 |
Raghavan D. Almost disjoint families and diagonalizations of length continuum Bulletin of Symbolic Logic. 16: 240-260. |
0.079 |
|
2020 |
Ragavan N, Selvaraj N, Raghavan D, Kamalakannan R, Govindaswamy TG, Balakrishnan AK, Jain N. Robot Assisted Laparoscopic Adrenalectomy: Does Size Matter? Cureus. 12: e9887. PMID 32968553 DOI: 10.7759/cureus.9887 |
0.079 |
|
2007 |
Raghavan D. We have a new sibling.. Colourage. 54: 24+26. |
0.077 |
|
2003 |
Raghavan D. Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder Urologic Oncology: Seminars and Original Investigations. 21: 468-474. PMID 14693275 DOI: 10.1016/S1078-1439(03)00145-5 |
0.077 |
|
1997 |
Huynh H, Raghavan D. Durability of simulated shredded rubber tire in highly alkaline environments Advanced Cement Based Materials. 6: 138-143. DOI: 10.1016/S1065-7355(97)81597-0 |
0.076 |
|
2007 |
Raghavan D. A matter of pride.. Colourage. 54: 28. |
0.076 |
|
2015 |
Damodharan S, Raghavan D. Combining tissue segmentation and neural network for brain tumor detection International Arab Journal of Information Technology. 12: 42-52. |
0.076 |
|
2000 |
Raghavan D. Advanced bladder and urothelial cancers European Journal of Cancer. 36. PMID 10908841 DOI: 10.1016/S0959-8049(00)00275-6 |
0.076 |
|
2000 |
Parimoo D, Raghavan D. Progress in the management of metastatic bladder cancer Cancer Control. 7: 347-356. PMID 10895129 |
0.075 |
|
2008 |
Raghavan D, Sandler HM. Multidisciplinary care of invasive bladder cancer: Emerging roles of chemotherapy Urological Oncology. 361-376. DOI: 10.1007/978-1-84628-738-1_20 |
0.075 |
|
2009 |
Kunen K, Raghavan D. Gregory trees, the continuum, and martin's axiom Journal of Symbolic Logic. 74: 712-720. DOI: 10.2178/Jsl/1243948337 |
0.074 |
|
2014 |
Raghavan D, Khan S. Use of Otoacoustic Emissions (OAE) to detect sub-clinical inner ear damage in divers of the Indian Navy. Medical Journal, Armed Forces India. 70: 344-8. PMID 25382908 DOI: 10.1016/j.mjafi.2014.04.004 |
0.073 |
|
1992 |
Raghavan D, Russell PJ, Brown JL. Experimental models of histogenesis and tumor cell heterogeneity in bladder cancer. Seminars in Surgical Oncology. 8: 279-84. PMID 1462098 DOI: 10.1002/ssu.2980080506 |
0.072 |
|
2007 |
Raghavan D. Auxiliaries... A new option for dyestuff manufacturers Colourage. 54: 26+28. |
0.072 |
|
2010 |
Brawley OW, Newman LA, Raghavan D. Reply to M. Moore et al Journal of Clinical Oncology. 28: e38. DOI: 10.1200/JCO.2009.25.2908 |
0.072 |
|
2015 |
Sekar A, Raghavan D. Implementation of single phase soft switched PFC converter for Plug-in-Hybrid Electric Vehicles Energies. 8: 13096-13111. DOI: 10.3390/en81112361 |
0.072 |
|
2016 |
Raghavan D. Systemic Therapy for Invasive Bladder Cancer: The Value Proposition. The Oncologist. PMID 27125752 DOI: 10.1634/theoncologist.2016-0074 |
0.07 |
|
1980 |
Raghavan D, Barrett A. Mediastinal seminomas Cancer. 46: 1187-1191. PMID 7214301 |
0.069 |
|
2015 |
Frenette G, Raghavan D. Principles of chemotherapy for genitourinary cancer Urological Oncology. 277-297. DOI: 10.1007/978-0-85729-482-1_13 |
0.069 |
|
2012 |
Raghavan D, Steprans J. On weakly tight families Canadian Journal of Mathematics. 64: 1378-1394. DOI: 10.4153/CJM-2012-017-8 |
0.068 |
|
1988 |
Raghavan D, Grundy R, Lancaster L. Assessment of quality of life in long-term survivors treated by first-line intravenous cisplatin for invasive bladder cancer Progress in Clinical and Biological Research. 260: 625-631. PMID 3362911 |
0.068 |
|
2014 |
Raghavan D, Yorioka T. Suslin Lattices Order. 31: 55-79. DOI: 10.1007/s11083-013-9288-2 |
0.068 |
|
2009 |
Lindner D, Raghavan D. Intra-tumoural extra-cellular pH: A useful parameter of response to chemotherapy in syngeneic tumour lines British Journal of Cancer. 100: 1287-1291. PMID 19367285 DOI: 10.1038/sj.bjc.6605022 |
0.068 |
|
2014 |
Raghavan D, Todorcevic S. Combinatorial dichotomies and cardinal invariants Mathematical Research Letters. 21: 379-401. DOI: 10.4310/Mrl.2014.V21.N2.A13 |
0.067 |
|
2012 |
Burgess EF, Raghavan D. Prostate cancer: What did we learn from the 2012 annual scientific meeting of ASCO? Oncology (United States). 26. |
0.067 |
|
2012 |
Burgess EF, Raghavan D. Prostate cancer: What did we learn from the 2012 annual scientific meeting of ASCO? Oncology (United States). 26. |
0.067 |
|
2005 |
Balakrishnan S, Raghavan D. Chemically functionalized clay vinyl ester nanocomposites II vernonia oil-based surfactant Journal of Reinforced Plastics and Composites. 24: 5-20. DOI: 10.1177/0731684405041712 |
0.067 |
|
2003 |
Balakrishnan S, Raghavan D. Synthesis of 13(14)-hydroxy-cis-10-nonadecenyl amine hydrochloride Jaocs, Journal of the American Oil Chemists' Society. 80: 503-508. |
0.066 |
|
2004 |
Raghavan D. Clinical problems in advanced bladder cancer Journal of B.U.On.. 9: 121-126. |
0.066 |
|
2010 |
Raghavan D. Bladder cancer: Optimal application of preclinical models to suitable translational questions Science Translational Medicine. 2: 22ps11. PMID 20374999 DOI: 10.1126/scitranslmed.3000215 |
0.065 |
|
1991 |
Raghavan D. Keynote address: A critical assessment of trials of neoadjuvant (preemptive) chemotherapy for bladder cancer: Lesson for future studies of combined modality treatment International Journal of Radiation Oncology, Biology, Physics. 20: 233-237. PMID 1991684 DOI: 10.1016/0360-3016(91)90096-M |
0.065 |
|
1996 |
Glaves D, Murray MK, Raghavan D. Novel bifunctional anthracycline and nitrosourea chemotherapy for human bladder cancer: Analysis in a preclinical survival model Clinical Cancer Research. 2: 1315-1319. PMID 9816302 |
0.063 |
|
2006 |
Raghavan D. Establishing the Colourage Centre of Excellence (COLOURAGE CoE) Colourage. 53. |
0.062 |
|
2006 |
Raghavan D. An investigation of the influence of interface chemical structure on fiber/matrix adhesion Materials Research Society Symposium Proceedings. 977: 132-135. |
0.061 |
|
2009 |
Raghavan D. Maximal almost disjoint families of functions Fundamenta Mathematicae. 204: 241-282. DOI: 10.4064/fm204-3-3 |
0.061 |
|
1980 |
Norgaard-Pedersen B, Raghavan D. Germ cell tumours: A collaborative review Oncodevelopmental Biology and Medicine. 1: 327-358. |
0.061 |
|
1989 |
Grant AJ, Russell PJ, Raghavan D. Elastase activities of human bladder cancer cell lines derived from high grade invasive tumours. Biochemical and Biophysical Research Communications. 162: 308-15. PMID 2751654 DOI: 10.1016/0006-291X(89)91997-9 |
0.061 |
|
2015 |
Raghavan D. Big data: Not really the same as level 1 data Oncology (United States). 29. PMID 25592212 |
0.059 |
|
2020 |
Selvaraj N, Thangarasu M, Jayaprakash S, Raghavan D, Paul R. Bladder Neck Resection Combined with Ten Point Intralesional Mitomycin C Injection in Management of Refractory Bladder Neck Contracture in Post TURP Status: A Single-Center, 2-Year Experience. Research and Reports in Urology. 12: 433-438. PMID 33062622 DOI: 10.2147/RRU.S267561 |
0.059 |
|
2000 |
Raghavan D, Egwim K. Degradation of polyester film in alkali solution Journal of Applied Polymer Science. 78: 2454-2463. DOI: 10.1002/1097-4628(20001227)78:14<2454::Aid-App40>3.0.Co;2-9 |
0.059 |
|
1990 |
Raghavan D. Towards the earlier diagnosis of testicular cancer Australian Family Physician. 19: 865-875. PMID 2174237 |
0.059 |
|
2015 |
Raghavan D, Lee TC, Curtin HD. Cholesterol Granuloma of the Petrous Apex: A 5-Year Review of Radiology Reports with Follow-Up of Progression and Treatment. Journal of Neurological Surgery. Part B, Skull Base. 76: 266-71. PMID 26225314 DOI: 10.1055/s-0034-1396600 |
0.058 |
|
1992 |
Raghavan D, Wagner GC, Wool RP. Carbon balance during biodegradation of a polymer Polymeric Materials Science and Engineering, Proceedings of the Acs Division of Polymeric Materials Science and Engineering. 67: 357-358. |
0.058 |
|
2010 |
Borden EC, Raghavan D. Personalizing medicine for cancer: The next decade Nature Reviews Drug Discovery. 9: 343-344. PMID 20431554 DOI: 10.1038/nrd3168 |
0.058 |
|
2015 |
Raghavan D. Point: Is cystectomy needed for small-cell bladder cancer? Oncology (United States). 29. |
0.057 |
|
1992 |
Raghavan D. Management of advanced bladder cancer in the elderly Urologic Clinics of North America. 19: 797-806. PMID 1441033 |
0.057 |
|
2008 |
Raghavan D. Textile processing machinery: Think projects, not only components Colourage. 55: 30+32. |
0.056 |
|
2013 |
Raghavan D. Invasive bladder cancer: Ignoring the data Oncologist. 18: 895-896. PMID 23986339 DOI: 10.1634/theoncologist.2013-0281 |
0.056 |
|
1981 |
Raghavan D. The applications of xenografts in the study of human germ cell tumours International Journal of Andrology. 4: 79-92. |
0.055 |
|
2012 |
Raghavan D. A model with no strongly separable almost disjoint families Israel Journal of Mathematics. 189: 39-53. DOI: 10.1007/s11856-011-0173-7 |
0.055 |
|
1990 |
Raghavan D, Guay R, Torma AE. A study of biodegradation of polyethylene and biodesulfurization of rubber - Scientific note Applied Biochemistry and Biotechnology. 24: 387-396. DOI: 10.1007/BF02920262 |
0.055 |
|
1995 |
Raghavan D. Adjuvant systemic therapy of prostate cancer Seminars in Oncology. 22: 633-640. PMID 8539638 |
0.054 |
|
2024 |
Taur P, Kannan D, Penchala Reddy N, Raghavan D. Renal Hydatid Cyst: Diagnostic Quandaries and Surgical Strategies. Cureus. 16: e66289. PMID 39238698 DOI: 10.7759/cureus.66289 |
0.054 |
|
1992 |
Boyer M, Raghavan D. Toxicity of treatment of germ cell tumors Seminars in Oncology. 19: 128-142. PMID 1313191 |
0.053 |
|
1992 |
Grimmond SM, Raghavan D, Russell PJ. Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing. Urological Research. 20: 121-6. PMID 1553789 DOI: 10.1007/BF00296523 |
0.053 |
|
2003 |
Raghavan D. Molecular targeting and pharmacogenomics in the management of advanced bladder cancer Cancer. 97: 2083-2089. PMID 12673700 |
0.053 |
|
1994 |
Boyer MJ, Raghavan D. Long-term morbidity of testicular cancer treatment Problems in Urology. 8: 154-166. |
0.053 |
|
2010 |
Raghavan D. There is a van douwen mad family Transactions of the American Mathematical Society. 362: 5879-5891. DOI: 10.1090/S0002-9947-2010-04975-X |
0.052 |
|
1996 |
Javle M, Raghavan D. Progress in the treatment of invasive bladder cancer Current Opinion in Urology. 6: 280-285. |
0.052 |
|
1990 |
Torma AE, Raghavan D. Biodesulfurization of rubber materials American Society of Mechanical Engineers, Bioengineering Division (Publication) Bed. 16: 81-87. |
0.052 |
|
2011 |
Chen C, Raghavan D. Thermally stable polymer nanocomposites Advances in Polymer Nanocomposite Technology. 175-198. |
0.05 |
|
1993 |
Raghavan D, Wagner GC, Wool RP. Aerobic biometer analysis of glucose and starch biodegradation Journal of Environmental Polymer Degradation. 1: 203-211. DOI: 10.1007/BF01458028 |
0.05 |
|
1998 |
Javle M, Raghavan D. Radiotherapy and chemotherapy for invasive bladder cancer Cancer Surveys. 31: 149-160. PMID 15281322 |
0.05 |
|
2007 |
Raghavan D. Shri Arvind Lalbhai - The end of a glorious era Colourage. 54: 24+26. |
0.049 |
|
2007 |
Raghavan D. Disparities in cancer care: Challenges and solutions Oncology. 21: 493-496. PMID 17474348 |
0.049 |
|
2008 |
Nargund VH, Raghavan D, Sandler HM. Urological oncology Urological Oncology. 1-634. DOI: 10.1007/978-1-84628-738-1 |
0.049 |
|
1997 |
Raghavan D, Koczwara B, Javle M. Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer European Journal of Cancer Part A. 33: 566-574. PMID 9274436 DOI: 10.1016/S0959-8049(96)00510-2 |
0.049 |
|
1991 |
Stockler M, Raghavan D. Neoplastic venous involvement and pulmonary embolism in patients with germ cell tumors Cancer. 68: 2633-2636. PMID 1657365 |
0.049 |
|
1979 |
Raghavan D, Murphy M. FATIGUE PROPERTIES OF 5456-H117 ALUMINUM ALLOY WELDMENTS Welding Journal (Miami, Fla). 58. |
0.048 |
|
2001 |
Raghavan D, Emekalam A. Characterization of starch/polyethylene and starch/polyethylene/poly(lactic acid) composites Polymer Degradation and Stability. 72: 509-517. DOI: 10.1016/S0141-3910(01)00054-4 |
0.048 |
|
2012 |
Raghavan D, Shelah S. Comparing the closed almost disjointness and dominating numbers Fundamenta Mathematicae. 217: 73-81. DOI: 10.4064/Fm217-1-6 |
0.048 |
|
2020 |
T M, Raghavan D, Muthu R, Prabhakar V, Prakash S. Collecting duct carcinoma of kidney: Masquerading as genitourinary tuberculosis - Lessons learnt. Urology Case Reports. 29: 101100. PMID 31890601 DOI: 10.1016/j.eucr.2019.101100 |
0.047 |
|
2012 |
Raghavan D. Salvage or savage chemotherapy for poor-risk or relapsed testis cancer-20 years later, not much has changed Annals of Oncology. 23: 813-814. PMID 22172324 DOI: 10.1093/annonc/mdr556 |
0.047 |
|
2014 |
Raghavan D. Testis cancer: The forgotten poster child Clinical Cancer Research. 20: 3630-3631. PMID 24812412 DOI: 10.1158/1078-0432.CCR-14-0691 |
0.047 |
|
2000 |
Raghavan D. Study of rubber-filled cementitious composites Journal of Applied Polymer Science. 77: 934-942. DOI: 10.1002/(Sici)1097-4628(20000725)77:4<934::Aid-App30>3.0.Co;2-L |
0.047 |
|
1994 |
Raghavan D, Tratt K, Wool RP. Recycled rubber in cement composites Materials Research Society Symposium - Proceedings. 344: 177-188. DOI: 10.1557/Proc-344-177 |
0.046 |
|
1995 |
Takita H, Blumenso LE, Raghavan D. Neoadjuvant chemotherapy of stage III-A and B lung carcinoma using the PACCO regimen Journal of Surgical Oncology. 59: 147-150. PMID 7609519 DOI: 10.1002/jso.2930590303 |
0.046 |
|
2006 |
Yim PJ, Vora AV, Raghavan D, Prasad R, McAullife M, Ohman-Strickland P, Nosher JL. Volumetric analysis of liver metastases in computed tomography with the fuzzy C-means algorithm. Journal of Computer Assisted Tomography. 30: 212-20. PMID 16628034 DOI: 10.1097/00004728-200603000-00008 |
0.045 |
|
2012 |
Raghavan D. Novel therapies for advanced prostate cancer: Have we have widened the goal posts too far? Annals of Oncology. 23: 2473-2475. PMID 22734010 DOI: 10.1093/annonc/mds185 |
0.045 |
|
2008 |
Kalmadi S, Raghavan D. Evolving perspectives of the role of novel agents in androgen-independent prostate cancer Indian Journal of Urology. 24: 303-308. DOI: 10.4103/0970-1591.42609 |
0.045 |
|
1997 |
Raghavan D. Management of invasive bladder cancer: Strategies of combined modality treatment Seminars in Radiation Oncology. 7: 37-44. |
0.045 |
|
1996 |
Raghavan D. Are Voltaire and Rousseau now wrong? Lancet. 348: 17. PMID 8973495 |
0.044 |
|
2008 |
Raghavan D. Hormone-Refractory prostate cancer: A rational approach to chemotherapy Urological Oncology. 536-543. DOI: 10.1007/978-1-84628-738-1_31 |
0.042 |
|
2022 |
Selvaraj N, Pooleri GK, Addla SK, Raghavan D, Govindaswamy TG, Balakrishnan AK, Sivaraman A, Jain N, Kandasamy SG, Ragavan N. Robot assisted laparoscopic adrenalectomy: Should this be the new standard? Urologia. 3915603221097166. PMID 35634982 DOI: 10.1177/03915603221097166 |
0.042 |
|
1991 |
Raghavan D, Shaligram AM, Deshpande DD. Influence of charge density and steric factor of aminated chloromethyl polystyrene homologs in bilirubin adsorption Journal of Applied Polymer Science. 42: 2483-2488. DOI: 10.1002/app.1991.070420913 |
0.041 |
|
2008 |
Raghavan D. Prostate cancer: Too much dogma, not enough data Cleveland Clinic Journal of Medicine. 75: 33-34. PMID 18236727 |
0.041 |
|
2003 |
Balakrishnan S, Raghavan D. Mechanical properties of chemically functionalized clay vinyl ester nanocomposites Materials Research Society Symposium - Proceedings. 791: 261-263. DOI: 10.1557/Proc-791-Q8.13 |
0.041 |
|
2022 |
Thangarasu M, Prakash JS, Bafna S, Aarthy P, Govindaswamy TG, Venugopal B, Sivaraman A, Jain N, Balakrishnan A, Raghavan D, Venkatraman M, Chandranathan M, Paul R, Selvaraj N, Ramakrishnan B, et al. Influence of tumor size in the progression of venous tumor thrombus in renal cell carcinoma: A 7-year single-center experience. Urology Annals. 14: 273-278. PMID 36117789 DOI: 10.4103/UA.UA_169_20 |
0.041 |
|
2024 |
Kannan D, Thangarasu M, Paul R, Meenashi Sundaram P, Raghavan D. Peritoneal Window With Omental Interposition as a Prophylactic Measure to Prevent Post-Renal Transplant Lymphocele: A Pilot Study. Cureus. 16: e68406. PMID 39360085 DOI: 10.7759/cureus.68406 |
0.04 |
|
1991 |
Raghavan D, Chye RWM. Treatment of carcinomatous meningitis from transitional cell carcinoma of the bladder British Journal of Urology. 67: 438-440. PMID 2032089 DOI: 10.1111/j.1464-410X.1991.tb15178.x |
0.04 |
|
2016 |
Raghavan D. Predicting Low Trial Accrual Mathematically: Is That the Right Emphasis? Journal of the National Cancer Institute. 108. PMID 26714556 DOI: 10.1093/jnci/djv379 |
0.039 |
|
2008 |
Raghavan D, Klein EA. Prostate cancer: moving forward by reinventing the wheel...but this time it is round. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4535-6. PMID 18626003 DOI: 10.1200/JCO.2008.18.3145 |
0.039 |
|
2002 |
Feresenbet E, Raghavan D, Holmes GA. Application of self assembled monolayer approach to probe fiber matrix-adhesion Materials Research Society Symposium - Proceedings. 710: 167-172. DOI: 10.1557/Proc-710-Dd11.4.1/Aa10.4.1 |
0.039 |
|
1990 |
Raghavan D. Testis cancer: the way forward Progress in Clinical and Biological Research. 357: 235-243. PMID 2170993 |
0.037 |
|
1982 |
Raghavan D, Coates A, Friedlander M. Mitoxantrone (XAN): Progress in a phase ii trial in Sydney, Australia Proceedings of the American Society of Clinical Oncology. |
0.037 |
|
1988 |
Raghavan D. Pre-emptive (neo-adjuvant) intravenous chemotherapy for invasive bladder cancer British Journal of Urology. 61: 1-8. PMID 3277688 DOI: 10.1111/j.1464-410X.1988.tb09152.x |
0.036 |
|
2003 |
Raghavan D. New prognostic factors for stage I testicular cancer: But will they make it to broadway? Journal of Clinical Oncology. 21: 4075-4076. PMID 14559887 DOI: 10.1200/JCO.2003.07.967 |
0.036 |
|
2013 |
Raghavan D. Cells, sieves, positive and negative attraction: But. slow progress in bladder cancer European Journal of Cancer. 49: 3065-3067. PMID 23845181 DOI: 10.1016/j.ejca.2013.06.007 |
0.035 |
|
2013 |
Lee TC, Raghavan D, Curtin HD. Image-guided percutaneous aspiration and gelfoam treatment of petrous apex cholesterol granuloma: a new theory and method for diagnosis and treatment. Journal of Neurological Surgery. Part B, Skull Base. 74: 342-6. PMID 24436935 DOI: 10.1055/s-0033-1345107 |
0.035 |
|
1996 |
Javle M, Raghavan D. Total androgen blockade for prostate cancer: the end does not justify the means Cancer Treatment and Research. 88: 201-210. PMID 9239481 |
0.035 |
|
2000 |
Raghavan D. 'Active surveillance' for stage I testis cancer: Attaining maturity at 21 years European Journal of Cancer. 36: 1891-1894. PMID 11000565 DOI: 10.1016/S0959-8049(00)00163-5 |
0.033 |
|
1993 |
Levine EG, Raghavan D. MVAC for bladder cancer: Time to move forward again Journal of Clinical Oncology. 11: 387-389. PMID 8445412 DOI: 10.1200/JCO.1993.11.3.387 |
0.033 |
|
2011 |
Raghavan D. Slow progress in cancer care disparities: HIPAA, PPACA, and CHEWBACCA... but were still not there! Oncologist. 16: 917-919. PMID 21804068 DOI: 10.1634/theoncologist.2011-0233 |
0.032 |
|
2016 |
Raghavan D. Cutaneous manifestations of genitourinary malignancy. Seminars in Oncology. 43: 347-52. PMID 27178687 DOI: 10.1053/j.seminoncol.2016.02.027 |
0.031 |
|
2013 |
Raghavan D. P-ideal dichotomy and weak squares Journal of Symbolic Logic. 78: 157-167. DOI: 10.2178/jsl.7801100 |
0.031 |
|
2008 |
Raghavan D. Chemicals and the Olympics! Colourage. 55: 30+32. |
0.031 |
|
2013 |
Raghavan D. Remembering old lessons in prostate cancer: Avoiding errors 'in PARPituity' Oncology (United States). 27. |
0.031 |
|
2013 |
Raghavan D. Remembering old lessons in prostate cancer: Avoiding errors 'in PARPituity' Oncology (United States). 27. |
0.031 |
|
2013 |
Raghavan D. In germ cell cancer, are we at the end of the chemotherapy era? No-targeted therapies have not heralded its demise Oncology (United States). 27. |
0.031 |
|
2013 |
Raghavan D. In germ cell cancer, are we at the end of the chemotherapy era? No-targeted therapies have not heralded its demise Oncology (United States). 27. |
0.031 |
|
2014 |
Govindarajan N, Raghavan D. Doubly fed induction generator based wind turbine with adaptive neuro fuzzy inference system controller Asian Journal of Scientific Research. 7: 45-55. DOI: 10.3923/ajsr.2014.45.55 |
0.03 |
|
2020 |
Selvaraj N, Thangarasu M, Prakash S, Raghavan D, Khakhar A. Acquired post cesarean uretero-uterine fistula - a rare entity. Urology Case Reports. 33: 101314. PMID 33102016 DOI: 10.1016/j.eucr.2020.101314 |
0.03 |
|
2016 |
Raghavan D, Jain R. Increasing awareness of sex differences in airway diseases. Respirology (Carlton, Vic.). 21: 449-59. PMID 26677803 DOI: 10.1111/resp.12702 |
0.03 |
|
2004 |
Raghavan D. Chemotherapy for prostate cancer: Small steps or leaps and bounds? No huzzahs just yet! British Journal of Cancer. 91: 1003-1004. PMID 15475939 DOI: 10.1038/sj.bjc.6602157 |
0.029 |
|
2007 |
Raghavan D. A yawning "gap" in our understanding of business and social norms Colourage. 54: 28+30. |
0.029 |
|
1999 |
Raghavan D. Prostate cancer management under scrutiny: One man's meta-analysis is another man's poisson Journal of Clinical Oncology. 17: 3371-3373. PMID 10550130 |
0.028 |
|
2011 |
Herliczek TW, Raghavan D, McCarten K, Wallach M. Sonographic upper gastrointestinal series in the vomiting infant: how we do it. Journal of Clinical Imaging Science. 1: 19. PMID 21966616 DOI: 10.4103/2156-7514.78528 |
0.028 |
|
1986 |
Grygiel J, Raghavan D. Clinical pharmacology and cancer chemotherapy an evolving interface? Medical Journal of Australia. 145: 458-463. PMID 3773833 |
0.028 |
|
1991 |
Levine EG, Raghavan D. Treatment of refractory testis cancer: Salvage or savage chemotherapy? European Journal of Cancer and Clinical Oncology. 27: 932-936. PMID 1657079 DOI: 10.1016/0277-5379(91)90150-C |
0.028 |
|
2007 |
Raghavan D. A wealth of riches in RCC treatment: How do we avoid 'devaluing the dollar'? Oncology. 21: 1187+1190. |
0.028 |
|
1997 |
Raghavan D. Prostate cancer, populations, politicians and power European Journal of Cancer (Oxford, England : 1990). 33: 329-330. PMID 9155513 |
0.028 |
|
1996 |
Raghavan D. Editorial: Perioperative chemotherapy for invasive bladder cancer - What should we tell our patients? Journal of Urology. 155: 1246-1247. PMID 8632541 DOI: 10.1016/S0022-5347(01)66231-1 |
0.028 |
|
2000 |
Abrha Y, Raghavan D. Polychlorinated biphenyl (PCB) recovery from spiked organic matrix using accelerated solvent extraction (ASE) and Soxhlet extraction Journal of Hazardous Materials. 80: 147-157. PMID 11080575 DOI: 10.1016/S0304-3894(00)00285-5 |
0.028 |
|
2007 |
Raghavan D. NPEO: The latest bad word in our industry Colourage. 54: 34+36. |
0.028 |
|
1982 |
Monaghan P, Raghavan D, Neville AM. Ultrastructural studies of xenografted human germ cell tumors Cancer. 49: 683-697. PMID 6173110 |
0.028 |
|
1990 |
Raghavan D. Chemotherapy for advanced bladder cancer: ‘midsummer night’s dream’ or ‘much ado about nothing’? British Journal of Cancer. 62: 337-340. PMID 2206939 DOI: 10.1038/bjc.1990.293 |
0.027 |
|
2016 |
Raghavan D, Holley JL. Conservative Care of the Elderly CKD Patient: A Practical Guide. Advances in Chronic Kidney Disease. 23: 51-6. PMID 26709063 DOI: 10.1053/j.ackd.2015.08.003 |
0.027 |
|
1988 |
Raghavan D. Chemotherapy in the management of invasive and metastatic bladder cancer European Urology. 14: 21-23. PMID 3053200 |
0.027 |
|
2008 |
Rapuano BE, Boursiquot R, Tomin E, Macdonald DE, Maddula S, Raghavan D, Lane JM, Helfet DL. The effects of COX-1 and COX-2 inhibitors on prostaglandin synthesis and the formation of heterotopic bone in a rat model. Archives of Orthopaedic and Trauma Surgery. 128: 333-44. PMID 18034350 DOI: 10.1007/S00402-007-0436-2 |
0.027 |
|
1989 |
Raghavan D. Non-seminomatous testicular cancer, 1989: Primum non nocere Australian and New Zealand Journal of Surgery. 59: 103-104. PMID 2919994 |
0.026 |
|
1998 |
Raghavan D. Bladder preservation in patients with bladder cancer--quality versus quantity of life? The Journal of Urology. 160: 1678-1679. PMID 9783930 |
0.026 |
|
2012 |
Raghavan D. Introduction: Bladder cancer Seminars in Oncology. 39: 523. PMID 23040248 DOI: 10.1053/j.seminoncol.2012.08.002 |
0.025 |
|
2009 |
Raghavan D. India on the move.. European Coatings Journal. 10-13. |
0.025 |
|
1993 |
Raghavan D. Chemotherapy for Bladder Cancer in the Elderly Drugs &Amp; Aging. 3: 1-8. PMID 8453182 DOI: 10.2165/00002512-199303010-00001 |
0.025 |
|
1999 |
Raghavan D. Editorial: Bladder preservation in patients with bladder cancer - Quality versus quantity of life? Journal of Urology. 160: 1678-1679. DOI: 10.1016/S0022-5347(01)62381-4 |
0.025 |
|
1995 |
Raghavan D. Characterization of biodegradable plastics Polymer-Plastics Technology and Engineering. 34: 41-63. DOI: 10.1080/03602559508017212 |
0.024 |
|
2012 |
Choueiri TK, Thakkar SG, Raghavan D. Adjuvant and neoadjuvant treatment for genitourinary cancers Principles and Practice of Surgical Oncology: a Multidisciplinary Approach to Difficult Problems. |
0.024 |
|
1981 |
Vogelzang NJ, Raghavan D, Savino D. Treatment of human testis cancer xenografts with a spermatocidal agent (win 18,446) Clinical Research. 29. |
0.024 |
|
1985 |
Raghavan D. Current status and controversies in the management of genito-urinary cancer Australian and New Zealand Journal of Surgery. 55: 243-248. PMID 3863577 |
0.024 |
|
1984 |
Raghavan D. Expectant therapy for clinical stage A nonseminomatous germ-cell cancers of the testis? A qualified "Yes", World Journal of Urology. 2: 59-63. DOI: 10.1007/BF00326936 |
0.023 |
|
2000 |
Beer T, Raghavan D. Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder Prostate. 45: 184-193. PMID 11027418 DOI: 10.1002/1097-0045(20001001)45:2<184::AID-PROS13>3.0.CO;2-K |
0.023 |
|
1993 |
Russell PJ, Plomley J, Raghavan D. The use of monoclonal antibodies for the diagnosis and therapy of bladder cancer. British Journal of Urology. 71: 121-9. PMID 8461941 |
0.023 |
|
2003 |
Raghavan D. Testicular cancer: Maintaining the high cure rate Oncology. 17: 218-228. |
0.022 |
|
2005 |
Raghavan D. The Renaissance clinician: Essential for the modern management of prostate cancer European Journal of Cancer. 41: 823-824. PMID 15808951 DOI: 10.1016/j.ejca.2005.02.003 |
0.022 |
|
2003 |
Raghavan D. Introduction: Perspectives in bladder cancer Cancer. 97: 2049. DOI: 10.1016/S0959-8049(98)00274-3 |
0.022 |
|
2013 |
Raghavan D. A structured approach to uncommon cancers: What should a clinician do? Annals of Oncology. 24: 2932-2934. PMID 24192449 DOI: 10.1093/annonc/mdt432 |
0.021 |
|
2005 |
Raghavan D. An eye on the future - India: One of the key markets in the coatings world European Coatings Journal. 16-17. |
0.021 |
|
1998 |
Raghavan D. Editorial: Progress in management of advanced prostate cancer - Don't throw the baby out with the bath water Journal of Urology. 160: 1230-1231. PMID 9751324 DOI: 10.1016/S0022-5347(01)62502-3 |
0.02 |
|
2009 |
Raghavan D. Controversies in the management of localized prostate cancer: after the rhetoric Oncology (Williston Park, N.Y.). 23: 833-835. PMID 19839424 |
0.02 |
|
1990 |
Raghavan D, Wallace M. Preemptive (neoadjuvant) chemotherapy: Can analysis of eligibility criteria, prognostic factors, and tumor staging from different trials provide valid or useful comparisons? Seminars in Oncology. 17: 613-618. PMID 2218574 |
0.02 |
|
1990 |
Russell PJ, O'Mara SM, Raghavan D. Ectopic hormone production by small cell undifferentiated carcinomas. Molecular and Cellular Endocrinology. 71: 1-12. PMID 2163929 DOI: 10.1016/0303-7207(90)90068-J |
0.019 |
|
2012 |
Raghavan D, Boxerman J, Rogg J, Cosgrove R. Glioblastoma multiforme: utilization of advanced MRI techniques for preoperative planning. Medicine and Health, Rhode Island. 95: 42-3. PMID 22474872 |
0.019 |
|
2013 |
Raghavan D. Testis cancer: On gilding the lily Annals of Oncology. 24: 269-270. PMID 23243194 DOI: 10.1093/annonc/mds611 |
0.019 |
|
2006 |
Raghavan D, Liu H, Stubbs J. Evaluation of biological responses of UMR-106 cells to porous PHBV matrix Materials Research Society Symposium Proceedings. 950: 136-141. |
0.018 |
|
2006 |
Raghavan D, Suh T. Cancer in the elderly population: The protection racket Journal of Clinical Oncology. 24: 1795-1796. PMID 16567764 DOI: 10.1200/JCO.2005.05.4502 |
0.017 |
|
2007 |
Raghavan D. Dedicated addressal of machinery in COLOURAGE Colourage. 54: 28+30. |
0.016 |
|
2013 |
Raghavan D. PSA: Please stop agonizing (over prostate- specific antigen interpretation) Mayo Clinic Proceedings. 88: 1-3. DOI: 10.1016/j.mayocp.2012.11.004 |
0.016 |
|
2013 |
Raghavan D. Costs of cancer care: Rhetoric, value, and steps forward Seminars in Oncology. 40: 659-661. PMID 24331187 DOI: 10.1053/j.seminoncol.2013.10.001 |
0.016 |
|
1998 |
Raghavan D. Managed care did not contribute to the development of curative treatment of germ cell tumors The Journal of Urology. 160: 1970. PMID 9817301 |
0.015 |
|
2004 |
Balakrishnan S, Raghavan D. Acrylic, elastomeric, particle-dispersed epoxy-clay hybrid nanocomposites: Mechanical properties Macromolecular Rapid Communications. 25: 481-485. DOI: 10.1002/Marc.200300111 |
0.015 |
|
2006 |
Raghavan D. Cotton: Indian textile industry's trump card Colourage. 53. |
0.015 |
|
2006 |
Raghavan D. An essay on rearranging the deck chairs: What's wrong with the cancer trials system? Commentary on Gray et al., p. 1966 Clinical Cancer Research. 12: 1949-1950. PMID 16608999 DOI: 10.1158/1078-0432.CCR-06-0424 |
0.014 |
|
1990 |
Raghavan D, Boyer M. Active surveillance for stage I non-seminomatous germ cell testis tumors: practice and pitfalls Progress in Clinical and Biological Research. 350: 309-318. PMID 2166960 |
0.013 |
|
1993 |
Jones VE, Raghavan D. Quantum leaps in treatment of high-risk breast cancer? Prove it! European Journal of Cancer. 29: 1488-1493. PMID 8398281 DOI: 10.1016/0959-8049(93)90027-D |
0.013 |
|
2015 |
Raghavan D. Choosing wisely: Where's the beef? Journal of Oncology Practice. 11: 325-326. DOI: 10.1200/JOP.2015.004663 |
0.013 |
|
2007 |
Raghavan D. Finishing ... The beginning of a healthy profitability Colourage. 54: 26+28. |
0.012 |
|
2006 |
Raghavan D. TUF(S) to comprehend! Colourage. 53. |
0.012 |
|
1991 |
Raghavan D. Clinician surrogates and equipoise: An analogy to lawyers who represent themselves? European Journal of Cancer and Clinical Oncology. 27: 1072-1074. PMID 1835615 DOI: 10.1016/0277-5379(91)90294-N |
0.011 |
|
1980 |
Raghavan D, Jelihovsky T, Fox RM. Father-son testicular malignancy. Does genetic anticipation occur? Cancer. 45: 1005-1009. PMID 7260832 |
0.011 |
|
2015 |
Nargund VH, Raghavan D, Sandler HM. Preface to first edition Urological Oncology. vii. DOI: 10.1007/978-0-85729-482-1 |
0.01 |
|
2012 |
Raghavan D, Boxerman J, Jeyapalan S, Rogg J. Radiation necrosis of a high-grade glioma. Medicine and Health, Rhode Island. 95: 159-60. PMID 22808637 |
0.01 |
|
2008 |
Raghavan D. Where the demand always exceeds the supply.. Colourage. 55: 30+32. |
0.01 |
|
2007 |
Raghavan D. Investments and the risk factor Colourage. 54: 20+22. |
0.01 |
|
2007 |
Raghavan D. "P" for death? Colourage. 54: 26+28. |
0.01 |
|
2007 |
Raghavan D. Co-branding - Tapping latent synergies Colourage. 54: 34+36. |
0.01 |
|
2006 |
Raghavan D. Indian Labour Law changes - Almoszt there, but not quite.. Colourage. 53. |
0.01 |
|
2006 |
Raghavan D. Mumbai textile mills: The fall of the last bastion? Colourage. 53: 38+40. |
0.01 |
|
2006 |
Raghavan D. Blame it on DMAI!!! Colourage. 53. |
0.01 |
|
2006 |
Raghavan D. Acceptability through Eco-Labelling in our textile industry Colourage. 53. |
0.01 |
|
2005 |
Raghavan D. Hidden by HIPAA: The costs of cure Journal of Clinical Oncology. 23: 3663-3665. PMID 15738543 DOI: 10.1200/JCO.2005.11.951 |
0.01 |
|
2004 |
Tesema Y, Raghavan D, Stubbs J. A comparative study of bone cell viability on collagen immobilized porous and non-porous poly(hydroxl) butyrate films Materials Research Society Symposium Proceedings. 61-63. |
0.01 |
|
1993 |
Raghavan D. Active surveillance for stage I testis cancer: Two steps forward one step back European Urology. 23: 49. PMID 8390361 |
0.01 |
|
1977 |
Collett P, Raghavan D, Salasoo S. Successful treatment of methotrexate-induced renal failure by haemodialysis Australian and New Zealand Journal of Medicine. 7: 441. |
0.01 |
|
Hide low-probability matches. |